Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

Phase 3

• Conditions: Rhegmatogenous Retinal Detachment

• Registration Number: NCT00370201
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

This clinical trial will test the efficacy and safety of oral colchicine in prevention of proliferative vitreoretinopathy (PVR) in cases of rhegmatogenous retinal detachment

Detailed Description

Not available

Study Timeline

• Status Verified: 2004-03
• Study Start: 2004-03
• Study Completion: 2006-08
• Study First Submitted: 2006-08-30
• Study First Submitted QC: 2006-08-30
• Study First Posted: 2006-08-31
• Last Update Submitted: 2006-10-06
• Last Update Posted: 2006-10-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Rhegmatogenous retinal detachment

Exclusion Criteria

• PVR grade C
• Duration of retinal detachment ≥ one month
• History of cataract surgery
• History of RD surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
proliferative vitreoretinopathy
retinal reattachment rate

Secondary Outcome Measures

Name	Time	Method
visual acuity
reoperation
macular pucker

Trial Locations

Locations (1)

Hamid Ahmadieh,MD; 🇮🇷 Tehran, Iran, Islamic Republic of